• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenecarboxylic acids and derivatives Naphthalenecarboxylic acids

Recent Advances in the Application of Methyl 5-bromo-2-naphthoate (CAS: 67878-76-6) in Chemical Biology and Pharmaceutical Research

Methyl 5-bromo-2-naphthoate (CAS: 67878-76-6) has emerged as a versatile building block in the synthesis of complex organic molecules, particularly in the fields of chemical biology and pharmaceutical research. This compound, characterized by its naphthalene core and bromo-substituent, serves as a key intermediate in the development of novel therapeutic agents and bioactive molecules. Recent studies have highlighted its potential in the synthesis of kinase inhibitors, fluorescent probes, and other biologically active compounds, making it a subject of growing interest in the scientific community.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers utilized Methyl 5-bromo-2-naphthoate as a precursor for the synthesis of a new class of tyrosine kinase inhibitors. The bromo-substituent at the 5-position of the naphthalene ring was found to be crucial for the inhibitory activity, as it facilitated the formation of a covalent bond with the target enzyme. The study demonstrated that derivatives of Methyl 5-bromo-2-naphthoate exhibited potent activity against a range of cancer cell lines, with IC50 values in the nanomolar range. These findings underscore the compound's potential as a scaffold for the development of targeted cancer therapies.

Another significant application of Methyl 5-bromo-2-naphthoate was reported in a 2022 ACS Chemical Biology article, where it was used to develop a series of fluorescent probes for imaging cellular processes. The bromo-substituent allowed for facile functionalization with various fluorophores, enabling the creation of probes with tunable emission wavelengths. These probes were successfully employed to monitor real-time dynamics of intracellular signaling pathways, providing valuable insights into cellular behavior under different physiological conditions. The study highlighted the compound's utility in chemical biology tools, which are essential for advancing our understanding of complex biological systems.

Recent advancements in synthetic methodologies have also expanded the utility of Methyl 5-bromo-2-naphthoate. A 2023 Organic Letters publication described a novel palladium-catalyzed cross-coupling reaction that efficiently transforms the bromo-substituent into a variety of functional groups, including aryl, alkenyl, and alkynyl moieties. This methodology has broadened the scope of accessible derivatives, enabling researchers to explore new chemical space for drug discovery. The study reported excellent yields and selectivity, making the process highly attractive for industrial-scale applications.

In the pharmaceutical industry, Methyl 5-bromo-2-naphthoate has gained attention as a key intermediate in the synthesis of antiviral agents. A 2023 patent application disclosed its use in the preparation of compounds with activity against RNA viruses, including SARS-CoV-2. The bromo-substituent was leveraged to introduce heterocyclic motifs that enhanced binding affinity to viral proteases. Preliminary data from this work showed promising antiviral activity, suggesting potential for further development into clinical candidates.

Looking ahead, the unique structural features of Methyl 5-bromo-2-naphthoate continue to inspire new applications in chemical biology and drug discovery. Its versatility as a synthetic intermediate, combined with the growing toolbox of transformation methods, positions this compound as a valuable asset in medicinal chemistry. Future research directions may include the exploration of its use in PROTACs (proteolysis targeting chimeras) and other emerging therapeutic modalities, as well as further optimization of its derivatives for improved pharmacokinetic properties.

• 38058-95-6(methyl 8-bromonaphthalene-1-carboxylate)
• 59866-97-6(methyl 5-bromonaphthalene-1-carboxylate)
• 16650-63-8(methyl 3-bromonaphthalene-1-carboxylate)
• 33626-98-1(Methyl 6-Bromo-2-napthoate)
• 1089318-91-1(Ethyl 10-bromoanthracene-9-carboxylate)
• 7473-73-6(1-Phenanthrenecarboxylicacid, 9-bromo-, methyl ester)
• 35615-97-5(Methyl 4-bromo-1-naphthoate)
• 26698-23-7(4-Phenanthrenecarboxylicacid, 10-bromo-, methyl ester)
• 51934-43-1(Ethyl 4-Bromo-1-naphthoate)
• 91271-31-7(Ethyl 5-bromo-1-naphthoate)